Bio-Techne
TECH
$86.96
Share price
0.45%
Change (1 day)
-10.20%
Change (1 year)
Categories
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.
Bio-Techne (TECH) - P/B ratio
P/B ratio as of March 2025 : 4.62
According to Bio-Techne's latest financial reports the company has a price-to-book ratio of 8.0259.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Bio-Techne - P/B ratio (from 2001 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | 5.58 | -10.23% |
| 2023-12-31 | 6.21 | -12.72% |
| 2022-12-31 | 7.12 | -40.37% |
| 2021-12-31 | 11.9 | 49.09% |
| 2020-12-31 | 8.01 | 26.12% |
| 2019-12-31 | 6.35 | 27.49% |
| 2018-12-31 | 4.98 | 2.4% |
| 2017-12-31 | 4.86 | 12.9% |
| 2016-12-31 | 4.31 | 10.21% |
| 2015-12-31 | 3.91 | -6.45% |
| 2014-12-31 | 4.18 | -10.47% |
| 2013-12-31 | 4.67 | 28.75% |
| 2012-12-31 | 3.63 | -14.24% |
| 2011-12-31 | 4.23 | -6.02% |
| 2010-12-31 | 4.50 | -13.98% |
| 2009-12-31 | 5.23 | -9.1% |
| 2008-12-31 | 5.75 | 4.03% |
| 2007-12-31 | 5.53 | -2.42% |
| 2006-12-31 | 5.67 | -26.33% |
| 2005-12-31 | 7.69 | 59.03% |
| 2004-12-31 | 4.84 | -17.16% |
| 2003-12-31 | 5.84 | 10.83% |
| 2002-12-31 | 5.27 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | P/B ratio differencediff. | Country |
|---|---|---|---|
 | 3.92 | -15.10% | 🇺🇸 USA |
 | 1.09 | -76.45% | 🇺🇸 USA |
 | 2.61 | -43.49% | 🇺🇸 USA |
 | 3.05 | -34.03% | 🇺🇸 USA |
 | 2.43 | -47.39% | 🇳🇱 Netherlands |
 | 11.1 | 139.73% | 🇺🇸 USA |
 | 0.5372 | -88.37% | 🇺🇸 USA |